iHuman
9 hedge funds and large institutions have $415K invested in iHuman in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0.16% less ownership
Funds ownership: 0.49% → 0.32% (-0.16%)
10% less funds holding
Funds holding: 10 → 9 (-1)
22% less capital invested
Capital invested by funds: $532K → $415K (-$117K)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$8.39K |
| 2 |
BlackRock
New York
|
+$713 |
| 3 |
EWA
EverSource Wealth Advisors
Birmingham,
Alabama
|
+$680 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$58.6K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$44.8K |
| 3 |
HF
HRT Financial
New York
|
-$38K |
| 4 |
VF
Virtu Financial
New York
|
-$26K |
| 5 |
Morgan Stanley
New York
|
-$7.13K |
IH Hedge Fund Activity: Q2 2025 in Review
9 of the 7,616 institutional investors tracked by Wall St. Rank reported a position in iHuman (IH) for Q2 2025, worth a combined $415K — down 22% from $532K a quarter earlier.
Fund positioning in IH was balanced in Q2 2025: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 4 trimmed.
The largest buyer was UBS Group, adding an estimated $8.39K. The largest seller was Two Sigma Securities, cutting an estimated $58.6K.
- 9 institutional investors held iHuman (IH) as of Q2 2025, down from 10 in Q1 2025.
- Funds reported $415K of iHuman stock for Q2 2025, down 22% quarter-over-quarter.
- 2 funds opened new iHuman positions in Q2 2025 and 2 closed out, a net change of 0 holders.
- The largest iHuman buyer in Q2 2025 was UBS Group, an estimated $8.39K added.
- The largest iHuman seller in Q2 2025 was Two Sigma Securities, an estimated $58.6K sold.
Based on aggregated 13F filings for Q2 2025.